ÂÜŔňÂŇÂ×

Scott Goldman has spent the past twenty years leading medical and scientific organizations in the civilian and government sectors. Prior to joining KSQ, Scott managed clinical antibody-drug-conjugate drug development programs at Mersana Therapeutics and served as an Alliance and Program Manager at the Broad Institute of MIT and Harvard, where he was responsible for corporate-sponsored research programs with Calico Labs and IBM Watson Health. While at the Broad, Scott spearheaded a “BioTech Startup” short course with Jason Ruth (MRL Ventures Fund and 5AM Ventures) and Tony Kulesa (Principal at Pillar VC, Founder of Petri) for medical, PhD, and MBA students across the Cambridge ecosystem. Before joining the Broad, Scott was a Veterinary Corps Officer in the U.S. Army for fifteen years. His assignments spanned the country and included everything from public health and animal care to serving as the Executive Officer of a major government biomedical research laboratory. He earned his PhD in Cellular and Molecular Pharmacology from Rutgers University where he studied autophagy, adipogenesis, and cancer imaging techniques. He earned his VMD from the University of Pennsylvania where he specialized in comparative medicine. Scott’s professional interests include non-traditional drug development, organizational change management, and leadership strategy.